Skip to main content

Table 2 Acute adverse events

From: Radiotherapy combined with gefitinib for patients with locally advanced non-small cell lung cancer who are unfit for surgery or concurrent chemoradiotherapy: a phase II clinical trial

Toxicity

Toxicity Grade

 

1

N(%)

2

N(%)

3

N(%)

4

N(%)

Skin

 Rash

9 (32.1)

0

0

0

 Radiation dermatitis

18 (64.3)

0

0

0

Hematologic toxicity

 Anemia

9 (32.1)

0

0

0

 Leukopenia

9 (32.1)

0

0

0

 Thrombocytopenia

0

0

0

0

Gastrointestinal toxicity

 Nausea

7 (25.0)

3 (10.7)

0

0

 Vomiting

1 (3.6)

1 (3.6)

0

0

 Diarrhea

1 (3.6)

0

1 (3.6)

0

Esophagitis

9 (32.1)

9 (32.1)

1 (3.6)

0

Hypohepatia

8 (28.6)

0

1 (3.6)

 

Renal function

6 (21.4)

0

0

0

Pneumonitis

2 (7.1)

7 (25.0)

0

0